导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.43% | 538/1050 |
| 近一周 | -1.91% | 370/1104 |
| 近一月 | 1.94% | 27/1102 |
| 近一季 | -8.14% | 588/1092 |
| 近半年 | -5.66% | 638/1070 |
| 近一年 | 10.41% | 345/1018 |
| 近两年 | 95.71% | 208/926 |
| 近三年 | 37.25% | 338/834 |
| 成立以来 | 122.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.96% 643/1070 |
13.85% 474/1101 |
- - |
- - |
| 2025 | 51.08% 183/1065 |
6.21% 321/1014 |
9.46% 122/1038 |
22.75% 513/1050 |
5.87% 110/1065 |
| 2024 | -4.81% 701/1011 |
-11.21% 802/960 |
-7.44% 765/983 |
9.46% 666/991 |
5.81% 114/1011 |
| 2023 | -19.93% 667/952 |
-6.94% 826/880 |
0.06% 188/895 |
-10.94% 618/915 |
-3.45% 373/952 |
| 2022 | -23.83% 461/867 |
-21.60% 615/773 |
8.35% 337/806 |
-5.98% 80/845 |
-4.62% 628/867 |
| 2021 | 17.50% 163/740 |
-19.07% 550/580 |
12.18% 306/659 |
10.10% 59/704 |
17.55% 8/740 |
| 2020 | 104.33% 22/554 |
-3.63% 254/419 |
21.42% 264/466 |
41.57% 1/517 |
23.34% 86/554 |
| 2019 | 32.93% 274/410 |
25.44% 674/1149 |
-7.04% 857/1231 |
9.18% 125/390 |
4.42% 355/410 |
| 2018 | -26.40% 166/349 |
- - |
- - |
- - |
-13.84% 818/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 博时军工主题股票A VS. 东吴新产业精选股票A(580008) |